Spero Therapeutics Inc (SPRO NASDAQ) stock market data APIs
$2.8016
-0.07(-2.5%)
as of May 15, 2026
Try our APIs with
free plan!
Spero Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include Tebipenem HBr (tebipenem pivoxil hydrobromide), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adult patients, which has completed second Phase 3 trial. It has license agreement with Meiji Seika Pharma Co., Ltd. to develop, manufacture, and commercialize tebipenem pivoxil and tebipenem HBr; and Everest Medicines to develop, manufacture, and commercialize SPR206 in Greater China, South Korea, and Southeast Asian countries. Spero Therapeutics, Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.
Prev. Close
2.8016
Open
2.7344
High
2.8928
Low
2.7055
52 wk Range
0.6463-3.22
Market Cap
160 M
P/E Ratio
10.2037
Shares Outstanding
57 901 K
Revenue
61 186 K
EPS
0.5309
Beta
1.433
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Spero Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Spero Therapeutics Inc data using free add-ons & libraries
Get Spero Therapeutics Inc Fundamental Data
Spero Therapeutics Inc Fundamental data includes:
- Net Revenue: 61 186 K
- EBITDA: 7 161 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-27
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Spero Therapeutics Inc News
New
Earnings Scheduled For May 13, 2026
Companies Reporting Before The Bell • Similarweb (NYSE:SMWB) is estimated to report quarterly earnings at $0.01 per share on revenue of $72.97 million. • Dominari Holdings (NASDAQ:DOMH) is proje...
GSK Q1 Earnings Beat Estimates, Specialty Medicines Drive Sales Growth
GSK plc GSK reported first-quarter 2026 core earnings of $1.26 per American depositary share (ADS), which beat the Zacks Consensus Estimate of $1.16. Core earnings rose 4% year over year on a reported...
Uncovering 3 Penny Stocks With Market Caps Under $700M
The market has climbed 1.2% in the last 7 days and is up 33% over the last 12 months, with earnings forecast to grow by 16% annually. Investing in penny stocks can still open doors to growth opportuni...
Spero Therapeutics Non-GAAP EPS of $0.53, revenue of $41.3M
* Spero Therapeutics press release [https://seekingalpha.com/pr/20453311-spero-therapeutics-announces-fourth-quarter-and-full-year-2025-operating-results-and-provides] (SPRO [https://seekingalpha.co...
Get Spero Therapeutics Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
